Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04793750 · ClinicalTrials.gov registry record · NA
Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 224
- Enrollment target
NCT04793750: Completed NA study, sponsored by Johns Hopkins University.
NCT04793750 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 224 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04793750, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 224 participants
- Enrollment target
Study Summary
This study proposes to investigate the performance of existing and new technologies for HIV diagnosis, one of the key strategies for Ending the HIV Epidemic in the U.S. Current, Standard-of-Care (SOC) diagnostic techniques have extended turn-around-times (TATs) that result in loss of patients to follow up due to delays in laboratory procedures. In this scenario, patients that are at a high-risk for HIV have the potential to continue transmission, making it difficult to end the epidemic. Rapid, Point-of-Care (POC) HIV viral load (VL) testing alleviates this problem by reducing TATs that allow providers to test for HIV infection and link patients to antiretroviral therapy (ART) or pre-exposure prophylaxis (PrEP) during the same clinical visit, and subsequently, suppress VL, prevent HIV infection, and reduce its transmission among high-risk populations. The study proposes that evaluating the performance of new and existing POC technologies is needed to provide updated information to HIV test providers operating in different populations and settings and improve linkage to HIV treatment and prevention services. The study hypothesizes that: A. Determining the performance characteristics of HIV POC tests will inform optimal testing strategies in different populations and settings B. The use of HIV RNA POC tests will improve linkage to HIV treatment and prevention services: i. Improve early diagnosis of HIV ii. Reduce the time to ART initiation iii. Facilitate timely and appropriate referral for prevention services
Interventions
- DIAGNOSTIC_TEST Cepheid GeneXpert HIV-1 Qual POC HIV VL test
- DIAGNOSTIC_TEST DPP HIV-Syphilis test system
- DIAGNOSTIC_TEST OraQuick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2021-08-18 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04793750
The ClinicalTrials.gov registry entry for NCT04793750 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cepheid GeneXpert HIV-1 Qual POC HIV VL test is the first listed.
NCT04793750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04793750 about?
NCT04793750 is a clinical study titled "Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)". This study proposes to investigate the performance of existing and new technologies for HIV diagnosis, one of the key strategies for Ending the HIV Epidemic in the U.S. Current, Standard-of-Care (SOC) diagnostic techniques have extended turn-around-times (TATs) that result in loss of patients to fol...
What is the current status of trial NCT04793750?
This trial is currently completed. It is a NA study. The enrollment target is 224 participants. The study started on 2021-08-18. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT04793750?
The interventions under investigation include: Cepheid GeneXpert HIV-1 Qual POC HIV VL test (DIAGNOSTIC_TEST), DPP HIV-Syphilis test system (DIAGNOSTIC_TEST), OraQuick (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04793750?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.